Human Growth Hormone Market - Forecast(2024 - 2030)

Key Takeaways

• In the coming years, growing interest in Human Growth Hormone is due to the rising awareness of the medical conditional between parents as well as Millennials.
• Product launch was a key sustainability strategy adopted by the market players to ensure the growth of Human Growth Hormone market.
• APAC region is estimated to record the fastest growth rate during the forecast period.

Application - Segment Analysis

In 2018, Growth Hormone Deficiency (GHD) segment dominated the Human Growth Hormone Market in terms of revenue. It is forecast to grow at a CAGR of 6.85% during the period under consideration. Growth Hormone Deficiency are caused by anterior pituitary disorder, metabolic disorder, tumors in pituitary gland and other reasons.

Route of Application - Segment Analysis

The Subcutaneous segment dominated the Human Growth Hormone market in 2018. Subcutaneous tissue layer of the skin has close contact with the muscles and tends to house majority of the body’s growth hormones. Amino acids such as arginine, lysine and ornithine can stimulate growth hormones when administered orally.

Distribution - Segment Analysis

In 2018, Hospital Pharmacies segment dominated the market in terms of revenue. As Human Growth Hormone are medicines prescribed by doctors, patients tend to purchase it from the hospital pharmacies to ensure appropriate cure.

Geography - Segment Analysis

In 2018, the North America region occupied 48% of the global Human Growth Hormone market in terms of revenue. The Human Growth Foundation says that in the U.S., approximately one in 4,000 to 10,000 children has GHD, and approximately 50,000 adults have GHD, with about 6,000 new adult patients are diagnosed every year. APAC region is estimated to record the fastest growth rate during the forecast period.

Drivers – Human Growth Hormone Market

• Growing Awareness of The Condition

Parents and millennials have recognized the prevalence of human growth disorders. Previously, these conditions were left ignored. But, the recent awareness and new drugs in the market have aided the evolvement of human growth hormone market.

Challenges – Human Growth Hormone Market

• Fear of side effects

Some studies concluded that human growth hormones have adverse effects on the human body in the long as these drugs are prepared with synthetically developed ingredients. This has left a certain group of people to steer clear from its usage. 

Human Growth Hormone Industry Outlook

Product Launches along is the key strategy of the players in the  Human Growth Hormone industry. The Human Growth Hormone top 10 companies include Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novo Nordisk A/S, Ipsen, Ferring BV, F. Hoffmann-La Roche, EMD Serono Inc., Eli Lilly and Company, & AnkeBio Co. Ltd.

Human Growth Hormone Market Research Scope:

The base year of the study is 2018, with forecast done up to 2025. The study presents a thorough analysis of the competitive landscape, taking into account the market shares of the leading companies. These provide the key market participants with the necessary business intelligence and help them understand the future of the Human Growth Hormone Market. The assessment includes the human growth hormone market size, forecast, an overview of the competitive structure, the human growth hormone market share of the competitors, as well as the market trends, market demands, market drivers, market challenges, and product analysis. The market drivers and restraints have been assessed to fathom their impact over the forecast period. This report further identifies the key opportunities for growth while also detailing the key challenges and possible threats. The key areas of focus include brand, application, route of administration, distribution channel & region.